BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22658537)

  • 21. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
    Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
    J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.
    Janusz MJ; Hookfin EB; Brown KK; Hsieh LC; Heitmeyer SA; Taiwo YO; Natchus MG; Pikul S; Almstead NG; De B; Peng SX; Baker TR; Patel V
    Inflamm Res; 2006 Feb; 55(2):60-5. PubMed ID: 16612565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
    Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
    Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new role for old ligands: discerning chelators for zinc metalloproteinases.
    Jacobsen FE; Lewis JA; Cohen SM
    J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deer (Cervus elaphus) antler extract suppresses adhesion and migration of endometriotic cells and regulates MMP-2 and MMP-9 expression.
    Kim JH; Yang YI; Ahn JH; Lee JG; Lee KT; Choi JH
    J Ethnopharmacol; 2012 Mar; 140(2):391-7. PubMed ID: 22313625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioinformatical and in vitro approaches to essential oil-induced matrix metalloproteinase inhibition.
    Zeidán-Chuliá F; Rybarczyk-Filho JL; Gursoy M; Könönen E; Uitto VJ; Gursoy OV; Cakmakci L; Moreira JC; Gursoy UK
    Pharm Biol; 2012 Jun; 50(6):675-86. PubMed ID: 22571397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
    J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors.
    Di Pizio A; Laghezza A; Tortorella P; Agamennone M
    ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent "clicked" MMP2 inhibitors: synthesis, molecular modeling and biological exploration.
    Zapico JM; Serra P; García-Sanmartín J; Filipiak K; Carbajo RJ; Schott AK; Pineda-Lucena A; Martínez A; Martín-Santamaría S; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2011 Jun; 9(12):4587-99. PubMed ID: 21552627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3β-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester, a novel natural product from Plumbago zeylanica inhibits the proliferation and migration of MDA-MB-231 cells.
    Sathya S; Sudhagar S; Vidhya Priya M; Bharathi Raja R; Muthusamy VS; Niranjali Devaraj S; Lakshmi BS
    Chem Biol Interact; 2010 Dec; 188(3):412-20. PubMed ID: 20670616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel molecular discovery of promising amidine-based thiazole analogues as potent dual Matrix Metalloproteinase-2 and 9 inhibitors: Anticancer activity data with prominent cell cycle arrest and DNA fragmentation analysis effects.
    Omar AM; Bajorath J; Ihmaid S; Mohamed HM; El-Agrody AM; Mora A; El-Araby ME; Ahmed HEA
    Bioorg Chem; 2020 Aug; 101():103992. PubMed ID: 32554279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9.
    Dufour A; Sampson NS; Li J; Kuscu C; Rizzo RC; Deleon JL; Zhi J; Jaber N; Liu E; Zucker S; Cao J
    Cancer Res; 2011 Jul; 71(14):4977-88. PubMed ID: 21646471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in the development of matrix metalloproteinase inhibitors.
    Tu G; Xu W; Huang H; Li S
    Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.
    Sasanelli R; Boccarelli A; Giordano D; Laforgia M; Arnesano F; Natile G; Cardellicchio C; Capozzi MA; Coluccia M
    J Med Chem; 2007 Jul; 50(15):3434-41. PubMed ID: 17583333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.
    Breuer E; Salomon CJ; Katz Y; Chen W; Lu S; Röschenthaler GV; Hadar R; Reich R
    J Med Chem; 2004 May; 47(11):2826-32. PubMed ID: 15139760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging.
    Breyholz HJ; Schäfers M; Wagner S; Höltke C; Faust A; Rabeneck H; Levkau B; Schober O; Kopka K
    J Med Chem; 2005 May; 48(9):3400-9. PubMed ID: 15857146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).
    Lin SS; Lai KC; Hsu SC; Yang JS; Kuo CL; Lin JP; Ma YS; Wu CC; Chung JG
    Cancer Lett; 2009 Nov; 285(2):127-33. PubMed ID: 19477063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis.
    Qu XJ; Yuan YX; Tian ZG; Xu WF; Chen MH; Cui SX; Guo Q; Gai R; Makuuchi M; Nakata M; Tang W
    Int J Mol Med; 2006 Oct; 18(4):609-14. PubMed ID: 16964412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.